Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 321.00
Bid: 320.90
Ask: 321.00
Change: 6.00 (1.90%)
Spread: 0.10 (0.031%)
Open: 320.00
High: 322.10
Low: 319.10
Prev. Close: 315.00
NWG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adam & Company Private Banking Business

17 Mar 2022 14:09

RNS Number : 1716F
NatWest Group plc
17 March 2022
 

NatWest Group plc

17 March 2022

 

Introduction

Following a detailed review on how its current Adam & Company clients can be best served, NatWest Group plc ("NatWest Group") intends that Coutts & Company will become its principal private bank offering. In order to implement this, it is intended to transfer the private banking (including execution-only dealing services and custody account services) and lending business carried on under the "Adam & Company" brand and trading name by The Royal Bank of Scotland plc ("RBS plc"), a public limited company incorporated in Scotland, to Coutts & Company ("Coutts"), a private unlimited company incorporated in England and Wales.

  

The Scheme

RBS plc and Coutts intend to effect this transfer by using a business banking transfer scheme under Part VII of the Financial Services and Markets Act 2000 ("FSMA").

 

Accordingly, on 17 March 2022 a Petition was presented to the Court of Session in Edinburgh (the "Court") by RBS plc and Coutts for an order under Part VII of the Financial Services and Markets Act 2000 sanctioning a banking business transfer scheme (the "Scheme") for the transfer of the private banking (including execution-only dealing services and custody account services) and lending business carried on by RBS plc under the "Adam & Company" brand and trading name from RBS plc to Coutts.

 

A hearing for the approval of the Scheme is expected to be held on 31 May 2022. If the Scheme is approved at that hearing, the Scheme is expected to take effect on 2 July 2022 or any later date which RBS plc and Coutts may agree, provided that it is no later than 11:59pm (GMT) on 2 October 2022. Implementation of the Scheme is subject, amongst other matters, to Court and regulatory approvals. Unless the context requires otherwise, capitalised terms used in this announcement are defined in the Scheme.

 

Further information on the Scheme

Copies of the Petition, the full terms of the Scheme and a summary of its principal terms are available free of charge at www.adambank.com/transfer or from 36 St Andrew Square, Edinburgh EH2 2YB and will remain available until the date of the Court hearing to consider sanctioning the Scheme.

 

For further information contact:

 

NatWest Group Investor Relations

Alexander HolcroftHead of Investor Relations+44 20 7672 1758

 

NatWest Group Media Relations

+44(0)131 523 4205

 

Making your views known

Any person claiming an interest may lodge formal written objections (known as "Answers") to the petition on or before 11 April 2022. Answers should be lodged at the Court of Session, Petition Department, Parliament House, Edinburgh EH1 1RQ, Scotland. If any person wishes to lodge Answers, they should seek independent legal advice. Answers are a formal Court document which must comply with the rules of the Court and are normally prepared by Scottish legal counsel. In addition, Answers must be accompanied by a fee to the Court.

 

Any person (including an employee of RBS plc or Coutts) who alleges that he or she would be adversely affected by the carrying out of the Scheme has a statutory right to be heard at the Court hearing to consider sanctioning the Scheme. The Court may also consider informal written objections to the Scheme. It would be helpful if anyone who wishes to exercise the statutory right to be heard, or to make informal written objections, could inform RBS plc, by post or by hand, on or before 11 April 2022 at 36 St Andrew Square, Edinburgh EH2 2YB. RBS will advise the Court accordingly and will pass on to the Court any written objections that it has received. No fee is payable for this.

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, such as statements that include, without limitation, the words 'expect', 'should', 'intend', 'could', 'may', 'will' and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as the future economic results, business plans and strategies of NatWest Group plc ("NatWest Group"). Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, the impact of the Covid-19 pandemic, future growth initiatives (including acquisitions, joint ventures and strategic partnerships), the outcome of legal, regulatory and governmental actions and investigations, the level and extent of future impairments and write-downs (including with respect to goodwill), legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations, general economic and political conditions and the impact of climate-related risks and the transitioning to a net zero economy. These and other factors, risks and uncertainties that may impact any forward-looking statement or NatWest Group plc's actual results are discussed in NatWest Group plc's UK 2021 Annual Report and Accounts (ARA) and NatWest Group plc's filings with the US Securities and Exchange Commission, including, but not limited to, NatWest Group plc's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this document speak only as of the date of this document and NatWest Group plc does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except to the extent legally required. 

 

Legal Entity Identifier

NatWest Group plc

2138005O9XJIJN4JPN90

The Royal Bank of Scotland plc

549300WHU4EIHRP28H10

Coutts & Company

549300OLXJ4Y010LOT3

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBSGDXRGBDGDR
Date   Source Headline
25th Aug 20224:32 pmRNSResult of General Meeting and Class Meeting
25th Aug 20222:00 pmRNSGeneral Meeting and Class Meeting Statement
12th Aug 20222:23 pmRNSUpdate to Financial Impact of Tender Offers
12th Aug 20227:00 amRNSH1 2022 Pillar 3 Supplements
11th Aug 202210:15 amRNSHolding(s) in Company
10th Aug 20226:18 pmRNSFinancial Impact of Tender Offers
10th Aug 20224:30 pmRNSDirector/PDMR Shareholding
9th Aug 20226:26 pmRNSResults of Tender Offers
9th Aug 202211:08 amRNSPricing of Tender Offers
9th Aug 20227:00 amRNSNotice of General Meeting and Class Meeting
1st Aug 20225:02 pmRNSTender Offer
1st Aug 20224:32 pmRNSPublication of Final Terms
29th Jul 20224:59 pmRNSPublication of Supplementary Prospectus
29th Jul 20223:19 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSInterim Results - NatWest Markets N.V.
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 2 of 2)
29th Jul 20227:00 amRNSInterim Results - NatWest Group (Part 1 of 2)
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
15th Jul 20226:05 pmRNSTransaction in Own Shares
14th Jul 20225:21 pmRNSTransaction in Own Shares
13th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20225:14 pmRNSTransaction in Own Shares
11th Jul 20225:21 pmRNSTransaction in Own Shares
8th Jul 20225:26 pmRNSTransaction in Own Shares
7th Jul 20225:27 pmRNSTransaction in Own Shares
6th Jul 20225:36 pmRNSTransaction in Own Shares
5th Jul 20225:46 pmRNSTransaction in Own Shares
4th Jul 20225:24 pmRNSTransaction in Own Shares
1st Jul 20225:43 pmRNSTransaction in Own Shares
30th Jun 20225:39 pmRNSTransaction in Own Shares
30th Jun 20223:03 pmRNSTotal Voting Rights
29th Jun 20225:35 pmRNSTransaction in Own Shares
28th Jun 20225:43 pmRNSTransaction in Own Shares
28th Jun 20221:33 pmRNSPricing of USD 5.516% Senior Callable Notes
27th Jun 20225:31 pmRNSTransaction in Own Shares
24th Jun 20225:28 pmRNSTransaction in Own Shares
23rd Jun 20225:38 pmRNSTransaction in Own Shares
21st Jun 20225:27 pmRNSTransaction in Own Shares
21st Jun 20222:30 pmRNSDirector/PDMR Shareholding
20th Jun 20225:31 pmRNSTransaction in Own Shares
17th Jun 20225:21 pmRNSTransaction in Own Shares
16th Jun 20225:31 pmRNSTransaction in Own Shares
14th Jun 20228:00 amRNSData Strategy Round Table
13th Jun 20225:14 pmRNSTransaction in Own Shares
10th Jun 20226:29 pmRNSTransaction in Own Shares
10th Jun 20227:23 amRNS2022 NatWest Group resolvability assessment report
9th Jun 20225:53 pmRNSTransaction in Own Shares
9th Jun 20227:30 amRNSGoldman Sachs European Financials Conference
8th Jun 20225:49 pmRNSTransaction in Own Shares
7th Jun 20225:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.